kallidin (Human) [4436]



kallidin (Human)


SMILES NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O
InChIKey FYSKZKQBTVLYEQ-FSLKYBNLSA-N
Sequence KRPPGFSPFR
HELM PEPTIDE1{K.R.P.P.G.F.S.P.F.R}$$$$

Chemical Properties

Hydrogen bond acceptors 15
Hydrogen bond donors 14
Rotatable bonds 33
Log P -4.375
Molecular weight (Da) 1187.7
Stereochemistry info unspecified

Database connections

Structure pdb 7F6I
Model (AF2) B1 B2

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

kallidin (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Structure pdb 7F6I
Model (AF2) B1 B2

Compound is not listed as a drug.